Abstract
Background: Chronic lymphocytic leukemia (CLL) represents the most frequent type of leukemia in the adult population. It is characterized by highly variable clinical course, predominantly initiated by different genetic alterations responsible for the regulation of cell proliferation and apoptosis. The aim of this study was to evaluate the relative expression of the BIRC3 gene in CLL patients. Methods: This cross-sectional study included 78 participants: a CLL group (n=50) and a control group of healthy subjects (n=28), both ageand sex-matched. To all participants, CBC (complete blood count), basic biochemical parameters, as well as FISH (fluorescent in situ hybridisation) for determining chromosomal aberrations and PCR analyses for determining the relative expression of the BIRC3 (Baculoviral IAP Repeat Containing 3) gene were performed. All reactions were performed on QIA quant 96 5 plex real-time PCR instrument (Qiagen, Hilden, Germany). Additionally, FISH diagnostics was performed using Abbott Vysis CLL FISH Probe Kit (Abbott Molecular diagnostics, Chicago, IL, USA). Results: Deletion of the long arm of the 13th chromosome was the most frequent chromosomal aberration in the CLL group. A statistically significant difference was observed in the relative expression of BIRC3, with higher values in the study group (p=0.019). The results of the binary logistic regression model indicated that lactate dehydrogenase and total calcium were statistically significant predictors of relative BIRC3 gene expression (p < 0.05). Conclusion: Determination of relative BIRC3 gene expression may be a valuable analysis for both the initial diagnosis and the clinical follow-up of CLL patients.

This publication has 24 references indexed in Scilit: